Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 12/20 | 0.56 |
| ▸ | MCHR1 | Q99705 | 4/20 | 0.54 |
| ▸ | LTA4H | P09960 | 1/20 | 0.54 |
| ▸ | BACE1 | P56817 | 1/20 | 0.53 |
| ▸ | HRH1 | P35367 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12439987 | 0.94 | LTA4H (0.62) | HRH3MCHR1LTA4HBACE1CYP2D6 | |
| SCHEMBL14039753 | 0.81 | MCHR1 (0.78) | HRH3MCHR1LTA4HCYP2D6CHRM1 | |
| SCHEMBL12440251 | 0.81 | MCHR1 (0.78) | HRH3MCHR1LTA4HCYP2D6CHRM1 | |
| SCHEMBL12440472 | 0.80 | MCHR1 (0.77) | HRH3MCHR1LTA4HCYP2D6CHRM1 | |
| SCHEMBL2322941 | 0.80 | MCHR1 (0.71) | MCHR1CYP2D6CHRM1HTR2A | |
| SCHEMBL12441623 | 0.79 | MAP4K4 (0.60) | HRH3MCHR1LTA4HBACE1CYP2D6 | |
| SCHEMBL12440309 | 0.79 | MCHR1 (0.76) | HRH3MCHR1LTA4HCYP2D6CHRM1 | |
| SCHEMBL12440372 | 0.79 | MCHR1 (0.74) | HRH3MCHR1LTA4HCYP2D6CHRM1 | |
| SCHEMBL21462645 | 0.78 | HRH3 (0.86) | HRH3LTA4HBACE1HRH1KCNH2 | |
| SCHEMBL12440442 | 0.78 | MCHR1 (0.65) | MCHR1LTA4HCYP2D6CHRM1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2357173-A1 | New alkyne compounds with MCH-antagonistic activity and medicaments containing them | Boehringer Ingelheim Pharma GmbH & Co. KG (DE) | 2011-08-17 | — | — | EP | disclosed |